Liver transplantation for hepatocellular carcinoma: Expansion of the tumor size limits does not adversely impact survival
By F. Yao, L. Ferrell, N. Bass, J. Watson, P. Bacchetti, A. Venook, N. Ascher, J. Roberts. Hepatology, 2001
2,183 citations recorded by the source corpus.
Subfields: Epidemiology, Hepatology, Surgery
View Paper: https://www.semanticscholar.org/paper/04c955a3b78be80719af82e98b2de67c594247ef
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
- J. Llovet
- Jordi Bruix1 , 2
- V. Mazzaferro
- Peter R. Galle
- Andrew X. Zhu
- Riccardo Lencioni
- M. Kudo
- M. Bernardi
In Hepatology
- Jordi Bruix1 , 2
- J. Llovet
- Riccardo Lencioni
- V. Mazzaferro
- Andrew X. Zhu
- Peter R. Galle
- T. de Baère
- T. Greten
In Surgery
Citations in the corpus
- Development of Hong Kong Liver Cancer staging system with treatment stratification for patients with hepatocellular carcinoma. (2014, background): “Patients would be considered for liver transplantation (LT) if they were within the Milan(24) or expanded University of California at San Francisco criteria.(25) If the patients were not surgical candidates, transarterial chemoembolization (TACE) or local ablative procedures such as percutaneous eth”
- Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma (2010, neutral): “[267] suggested an expanded”
- EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. (2012, background): “5 cm and total tumor diameter 68 cm) – which involves around 5–10% of all enlisted patients [220,232] – has already been challenged from the pathological point of view by the up-to-seven criteria (i.”
- EASL Clinical Practice Guidelines: Liver transplantation. (2016, background): “[80] have shown that patients with one nodule <6.”
- Resection and Liver Transplantation for Hepatocellular Carcinoma (2005, methodology): “The model relies on number and size of the nodules identified by radiological preoperative staging (R)(19,26,27,104) or pathological staging (P).(22,28,29) Outcomes reflect published data or expected survival in prospective studies (E).”
- Management of hepatocellular carcinoma: An update (2011, neutral): “This has recently fuelled a debate about whether and to what extent the indications for transplantation as therapy for HCC can be expanded.(25,280-285) There are very limited data to support extending the selection criteria.”
- Overexpression of Long Non-coding RNA HOTAIR Predicts Tumor Recurrence in Hepatocellular Carcinoma Patients Following Liver Transplantation (2011, background): “More recently, the Milan criteria have been criticized for being too restrictive, and some patients with tumors beyond Milan criteria may also experience low risk of recurrence.(12,14,15) Therefore, molecular classification of HCC patients with tumors outside the Milan criteria TABLE 2 Univariate an”
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update (2017, background): “(UCSF) criteria: solitary tumor B65 mm in diameter, or 2–3 tumors, each with diameter B45 mm and total tumor diameter B80 mm, and without radiological evidence of vascular invasion or distant metastasis [417].”